Expert Consensus on the Treatment of Rheumatoid Arthritis with Chinese Patent Medicines
Author:
Affiliation:
1. Institute of Basic Research in Clinical Medicine, China Academy of Traditional Chinese Medicine, Dongzhimen, Beijing, China.
2. Jiangxi College of Traditional Chinese Medicine, Nanchang, Jiangxi Province, China.
Publisher
Mary Ann Liebert Inc
Subject
Complementary and alternative medicine
Link
http://www.liebertpub.com/doi/pdf/10.1089/acm.2011.0370
Reference37 articles.
1. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
2. Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications
3. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature
4. Rheumatoid Arthritis: An Overview of New and Emerging Therapies
5. Pericardial effusions on anti-TNF therapy for rheumatoid arthritis--a drug side effect or uncontrolled systemic disease?
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Network Pharmacology-based and Molecular Docking Combined with GEO Gene Chips to Investigate the Potential Mechanism of Duhuo Jisheng Decoction against Rheumatoid Arthritis;Current Computer-Aided Drug Design;2024-08
2. Therapeutic effect of Duhuo Jisheng Decoction add-on Tui-na manipulation on osteoarthritis of knee: a randomized controlled trial;Chinese Medicine;2023-07-10
3. Effectiveness and Safety of Duantengyimu-tang for Rheumatoid Arthritis: A Protocol for a Systematic Review and Meta-Analysis;Perspectives on Integrative Medicine;2023-06-30
4. Integrated Multi-Omics Techniques and Network Pharmacology Analysis to Explore the Material Basis and Mechanism of Simiao Pill in the Treatment of Rheumatoid Arthritis;ACS Omega;2023-03-20
5. Wangbi granule as a combination therapy to achieve clinical deep remission in rheumatoid arthritis: protocol for a multicenter, triple-blind, randomised, placebo-controlled trial;Chinese Medicine;2023-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3